1. Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
- Author
-
Tutt, Andrew N.J., primary, Garber, Judy E., additional, Kaufman, Bella, additional, Viale, Giuseppe, additional, Fumagalli, Debora, additional, Rastogi, Priya, additional, Gelber, Richard D., additional, de Azambuja, Evandro, additional, Fielding, Anitra, additional, Balmaña, Judith, additional, Domchek, Susan M., additional, Gelmon, Karen A., additional, Hollingsworth, Simon J., additional, Korde, Larissa A., additional, Linderholm, Barbro, additional, Bandos, Hanna, additional, Senkus, Elżbieta, additional, Suga, Jennifer M., additional, Shao, Zhimin, additional, Pippas, Andrew W., additional, Nowecki, Zbigniew, additional, Huzarski, Tomasz, additional, Ganz, Patricia A., additional, Lucas, Peter C., additional, Baker, Nigel, additional, Loibl, Sibylle, additional, McConnell, Robin, additional, Piccart, Martine, additional, Schmutzler, Rita, additional, Steger, Guenther G., additional, Costantino, Joseph P., additional, Arahmani, Amal, additional, Wolmark, Norman, additional, McFadden, Eleanor, additional, Karantza, Vassiliki, additional, Lakhani, Sunil R., additional, Yothers, Greg, additional, Campbell, Christine, additional, and Geyer, Charles E., additional
- Published
- 2021
- Full Text
- View/download PDF